Latest
Open
RNA-Seq
ChIP-Seq
SNP
Assembly
Tutorials
Tools
Jobs
Forum
Planet
All »
Home
Log In
Question: question about survival analysis of TCGA mRNA expression data
0
gravatar for tujchl02
2.1 years ago by
tujchl02 • 10
tujchl02 • 10 wrote:

Hi I just want to do some simple survival analysis using TCGA expression data. I use survival package in R. Firstly I must divide the data into two parts. The one is patients with low expression of gene A and the other is patients with high expression of gene A. Then I plot the survival curve in R and calculate significant P value. The criterion to divide the data which I used is the mean value of mRNA expression value of whole data. My question is whether this criterion is suitable or not. Do you have some suggestions? Could you please give me some reference?
survival analysis tcga • 2.1k views
ADD COMMENT • link •
modified 13 months ago by Kevin Blighe ♦ 48k • written 2.1 years ago by tujchl02 • 10

Check http://www.oncolnc.org/ and Survival analysis of TCGA patients integrating gene expression (RNASeq) data

ADD REPLY • link written 2.1 years ago by Santosh Anand ♦ 4.9k
1

Thank you. I am reading them

ADD REPLY • link written 2.1 years ago by tujchl02 • 10
0
gravatar for Kevin Blighe
13 months ago by
Kevin Blighe ♦ 48k
Kevin Blighe ♦ 48k wrote:

If all that you need to hear is whether or not it is okay to divide 'high' and 'low' expression based on the mean, then the answer is: 'yes, it is okay'. You can also do the following:

  • divide based on the median
  • divide based on upper-, middle-, and lower tertiles
  • divide by quartiles
  • divide expression based on some other clinical trait
  • et cetera.

You can take a look here, in addition: A: cox proportional hazard model

I'm giving an answer so that this thread will not be bumped up further to the main page.

Kevin
ADD COMMENT • link written 13 months ago by Kevin Blighe ♦ 48k
Please log in to add an answer.

Similar posts • Search »

Content
Help
Access
Use of this site constitutes acceptance of our User Agreement and Privacy Policy.
Powered by Biostar version 2.3.0
Traffic: 817 users visited in the last hour